Photo Source: Ministry of Health of the Russian Federation
Between 2018 and 2024, 4.7 billion rubles were allocated to the development and implementation of these technologies, with 69% from government funding and 29% from private investors. Moscow contributed a significant portion of all government investment, allocating 1.8 billion rubles (38% of the total) to an experimental computer vision technology program.
In 2023-2024, more than 400 implementations of registered AI medical devices occurred across 84 Russian regions, averaging approximately 4-5 services per region. According to the Ministry of Health's plan, by 2030 every region will deploy at least 12 medical data analysis solutions.
Moscow's city government made the largest contribution to computer vision technology development, conducting a large-scale medical image analysis experiment. Over five years, more than 20 million images were processed and 204 AI services from 39 companies were tested, of which 116 (57%) operated in actual clinical practice. Moscow was the first to establish grant support for developers.
Beyond officially registered devices, experimental AI developments for medical purposes are being created in research centers under the Ministry of Health, as well as in medical schools, research institutes, and other institutions nationwide. Ministry of Health clinics and centers are developing over 200 AI products: 150 for diagnostics, 37 for treatment, and 23 for prevention. The highest number of developments are in oncology, internal medicine, and obstetrics and gynecology.
One example is the A.N. Ryzhikh National Medical Research Center of Coloproctology's solution for detecting rectal cancer. The system, called ArtInCol, operates during endoscopic examination (colonoscopy) and uses machine vision to detect even the most inconspicuous colorectal neoplasms, including early-stage cancers.
More active implementation of AI solutions was facilitated by the inclusion of medical image analysis in mandatory health insurance coverage beginning last year. According to the Federal Mandatory Medical Insurance Fund and the Ministry of Health, in 2024 and the first two months of 2025, medical organizations performed 1.39 million AI-assisted studies totaling approximately 415.5 million rubles. The most active regions by number of such studies, besides Moscow (approximately 328,000), are Kemerovo Oblast (150,000), Voronezh Oblast (134,000), Saratov Oblast (86,000), and Krasnodar Krai (78,000).
Over eight months in 2025, 1.2 million AI-assisted mammographies were performed in 59 regions, 2.8 million X-rays and fluorographies in 48 regions, and 135,000 chest CT scans in 40 regions.
Source: TASS
All information on this website is provided for informational purposes only and does not constitute medical advice. All medical procedures require prior consultation with a licensed physician. Treatment outcomes may vary depending on individual characteristics. We do not guarantee any specific results. Always consult a medical professional before making any healthcare decisions.